These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32751286)

  • 1. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells.
    Feitz WJC; van de Kar NCAJ; Cheong I; van der Velden TJAM; Ortiz-Sandoval CG; Orth-Höller D; van den Heuvel LPJW; Licht C
    Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin
    Feitz WJC; Bouwmeester R; van der Velden TJAM; Goorden S; Licht C; van den Heuvel LPJW; van de Kar NCAJ
    Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model.
    Bova RA; Lamont AC; Picou TJ; Ho VB; Gilchrist KH; Melton-Celsa AR
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin.
    Feitz WJC; van Setten PA; van der Velden TJAM; Licht C; van den Heuvel LPJW; van de Kar NCAJ
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome.
    Hostetter SJ; Helgerson AF; Paton JC; Paton AW; Cornick NA
    BMC Res Notes; 2014 Jun; 7():331. PubMed ID: 24890228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
    Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).
    Exeni RA; Fernandez-Brando RJ; Santiago AP; Fiorentino GA; Exeni AM; Ramos MV; Palermo MS
    Pediatr Nephrol; 2018 Nov; 33(11):2057-2071. PubMed ID: 29372302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga Toxin 2a Induces NETosis via NOX-Dependent Pathway.
    Feitz WJC; Suntharalingham S; Khan M; Ortiz-Sandoval CG; Palaniyar N; van den Heuvel LP; van de Kar NCAJ; Licht C
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga Toxin 2a-Induced Endothelial Injury in Hemolytic Uremic Syndrome: A Metabolomic Analysis.
    Betzen C; Plotnicki K; Fathalizadeh F; Pappan K; Fleming T; Bielaszewska M; Karch H; Tönshoff B; Rafat N
    J Infect Dis; 2016 Mar; 213(6):1031-40. PubMed ID: 26582960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease.
    Pradhan S; Pellino C; MacMaster K; Coyle D; Weiss AA
    Front Cell Infect Microbiol; 2016; 6():114. PubMed ID: 27747196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
    Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2019 Mar; 34(3):379-388. PubMed ID: 29214442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome.
    Petruzziello-Pellegrini TN; Moslemi-Naeini M; Marsden PA
    Virulence; 2013 Aug; 4(6):556-63. PubMed ID: 23955166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation.
    Bowen EE; Hurcombe JA; Barrington F; Keir LS; Farmer LK; Wherlock MD; Ortiz-Sandoval CG; Bruno V; Bohorquez-Hernandez A; Diatlov D; Rostam-Shirazi N; Wells S; Stewart M; Teboul L; Lay AC; Butler MJ; Pope RJP; Larkai EMS; Morgan BP; Moppett J; Satchell SC; Welsh GI; Walker PD; Licht C; Saleem MA; Coward RJM
    Med; 2023 Nov; 4(11):761-777.e8. PubMed ID: 37863058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome.
    Brigotti M; Carnicelli D; Arfilli V; Porcellini E; Galassi E; Valerii MC; Spisni E
    Int J Med Microbiol; 2018 Oct; 308(7):940-946. PubMed ID: 29983334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of Shiga toxin in environmental Escherichia coli O145:H28 strains carrying the same genotype as the outbreak strains.
    Carter MQ; Pham A; Du WX; He X
    Int J Food Microbiol; 2021 Feb; 339():109029. PubMed ID: 33360585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.